Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Sluggishness, Vaccination site erythema
Clinical narrative: feeling tired; sluggish; mild redness at the injection site; arm was sore; This is a spontaneous report received from a contactable reporter(s) (Other HCP).  A 36 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 01Sep2021 08:53 (Lot number: EW0153) at the age of 36 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Short of breath" (unspecified if ongoing); "Cardiovascular" (unspecified if ongoing); "Difficulty speaking" (unspecified if ongoing); "Drooling" (unspecified if ongoing); "Difficulty swallowing" (unspecified if ongoing), notes: Without swelling noted; "Measured hypotension" (unspecified if ongoing), notes: Fluctuating blood pressure high+low; "decreased consciousness" (unspecified if ongoing), notes: Self reported; "Heartbeat irregular" (unspecified if ongoing); "Numbness" (unspecified if ongoing); "Tingling" (unspecified if ongoing); "Felt eye" (unspecified if ongoing); "Shaking" (unspecified if ongoing); "Trembling" (unspecified if ongoing). Concomitant medication(s) included: ZOLPIDEM taken for sleep disorder. Past drug history included: Ativan; Fluoxetine, notes: Fluoxetine (for approx. 4 years). Vaccination history included: Bnt162b2 (Dose 1, time of vaccination 11:23, Lot number EH9899, Anatomical location: Left arm, Route: Intramuscular), administration date: 21Dec2020, when the patient was 35 years old, for COVID-19 immunization; Bnt162b2 (Dose 2, time of vaccination 11:32, Lot number EL1284, Anatomical location: Left arm, Route: Intramuscular), administration date: 11Jan2021, when the patient was 35 years old, for COVID-19 immunization; Influenza (Most recent non-covid vaccine was influenza administered in Oct/Nov 2020). The following information was reported: FATIGUE (non-serious) with onset 2021, outcome "unknown", described as "feeling tired"; SLUGGISHNESS (non-serious) with onset 2021, outcome "unknown", described as "sluggish"; VACCINATION SITE ERYTHEMA (non-serious) with onset 2021, outcome "unknown", described as "mild redness at the injection site"; PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "arm was sore". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: The patient did not have known allergies. This patient described having anxiety related to vaccination but decided to receive three doses. The patient received a third dose of vaccine on 01Sep2021 without recurrence of the symptoms associated with administration of the second dose, she reported feeling tired and sluggish and had some mild redness at the injection site and her arm was sore, but not cardiac, respiratory, or histamine-mediated allergic symptoms were noted following the third dose. The patient did not receive any recent vaccines for any other conditions prior to the event being reported. Patient did not receive any recent vaccines for SARS-CoV2 other than Pfizer-BioNTech COVID-19 Vaccine prior to the event being reported and not received any other vaccines around the time of Pfizer-BioNTech COVID-19 Vaccine vaccination.  No follow-up attempts are possible. No further information is expected.